HONG KONG, June 11, 2014 /PRNewswire/ -- China Cord
Blood Corporation (NYSE: CO) (the "Company") today announced its
plan to release financial results for the fourth quarter and full
fiscal year ended March 31, 2014 on
Wednesday, June 18, 2014, after
the market closes in the U.S.
The Company will host a conference call at 8:00 a.m. ET on Thursday,
June 19, 2014 to discuss its financial performance and give
a brief overview of the Company's recent developments, followed by
a question and answer session. Interested parties may access the
audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be
accessible two hours after the conference call and available for
three weeks at the same URL link
above. Listeners may also access the call by dialing 1-631-514-2526
or 1-855-298-3404 for U.S. callers or +852-5808-3202 for
Hong Kong callers, access code:
1106709.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the fourth quarter and fiscal year 2014 earnings press
release will be available at http://www.chinacordbloodcorp.com, in
the section titled Investor Center/Press Release, after
4:00 p.m. ET on Wednesday, June 18, 2014 and in the Company's
Report on Form 6-K for the month of June
2014 available on the Securities and Exchange Commission's
website at www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses. Under
current PRC government regulations, only one licensed cord blood
banking operator is permitted to operate in each licensed region
and only seven licenses have been authorized as of today. China
Cord Blood Corporation provides cord blood collection, laboratory
testing, hematopoietic stem cell processing and stem cell storage
services. For more information, please visit the Company's website
at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: william.zima@icrinc.com
SOURCE China Cord Blood Corporation